Category: Misuse and Dependence

Articles About Misuse and Dependence

Activities and Behaviors such as sex, shopping, surfing the internet, gambling, pain-seeking, cutting, viewing or attaining pornography, eating, playing video games, exercising…
Because misuse and dependence is complex, treatment can be complex also. In these articles about misuse and dependence, you’ll find posts about how ketamine can reduce or stop craving. You may still require counseling or psychotherapy to help you change your thinking patterns that lean toward misuse and dependent behaviors. Even so, it can be an immeasurable help to not have to fight cravings in the process.
The rule of thumb is to consider whether the use of a substance or a behavior interferes with your daily living. Does it affect your relationships at home, or socially? Does it interfere with your family life? How about your relationships with co-workers, as well as your work performance? Are you breaking any laws?

Denial is the first and perhaps hardest obstacle to overcome so you can seek treatment. When you evaluate the role this substance or behavior plays in your life, the objective opinion of a close friend or family member might add .some distance and perspective

IV ketamine treatment has emerged as a rapid and robust treatment for depression and other psychiatric disorders. Elias Dakwar, M.D., has done exceptional work demonstrating ketamine’s ability to stop craving in patients with dependencies.

Ketamine is proving to be a dynamic tool to break the craving cycle and to enhance psychotherapy by providing neuroplasticity to support change.
Since many dependencies are accompanied by depression, IV ketamine treatment can also slash the depression while reducing craving and enhancing psychotherapy.

Keep reading to learn more.

  • Family: Suffering Together With Psychiatric Disorders

    Family: Suffering Together With Psychiatric Disorders

    If you have a family suffering together with psychiatric disorders reach out for support. You all need it.

    “I don’t care what the &%@!* you think!! It’s all your fault!! I’m outta here!!!”

    With that, Ben picked up the massive carved oak coffee table and  threw it at the window. It hit the window and the wall with a thud, pushing the window frame in a contorted mangle of metal and glass out toward the garden, knocking a gash into the wall with the impact. Families that are suffering together with psychiatric disorders know this scene so well…

    The table fell to the floor, unaffected by its collision, except for a few paint scrapes off the wall. The wall, however, didn’t do so well.

    By then, Ben had already grabbed a china lamp and slung it toward another window. The shattering glass of the window and the shattering china in the lamp base formed a tinkling wind-chimes sort of symphony as they fell.

    Ben beat his face with both fists, cursing his life.

    Suffering Together

    A little girl like this one can be lost in the chaos when a family suffering from psychiatric disorders is in turmoil.

    Little 6-year-old Sara shrank back into the shadows of the hallway. She knew not to cross her big brother at times like this. He was her hero and had been her best friend ever since she was born.  He was kind, patient and included her even though he was 7 years older. 

    It scared her when he got like this, but she also instinctively knew he just couldn’t help it.  She knew he’d probably cry again after this rage subsided, because he felt so helpless to control it and so sad about hurting the family.

    She slipped back into her room and quietly closed the door to play with her dolls…and try to not hear what was happening.

    Then her mom’s gentle voice sounded soothing and reassuring. She was helping him calm down, like she had so many times before. After 30 minutes or so  (it was hard to tell time, but especially when every second seems like an eternity…) she heard Ben trying to talk through sobs… she knew what he was probably saying, and she wanted to go hug him. But she thought it was better to let mom do that right now. He might be embarrassed to know she heard all of that.

    Each One Copes in His Own Way

    Sara felt confident the “storm” had passed, but then the front door slammed so hard the house seemed to crack. She quietly opened her door to look and listen. Ben and Mom were talking in low tones in the living room…but she could see her older brother’s door was open.

    Then a car started and screeched away outside.

    Ohhhhh.  I guess Ben’s episode made Gregory mad again.  (Huge sigh)  I wish everyone could just be happy.  We must be the only family that goes through this.. 

    Out of nowhere Scruffy, their mixed breed little dog, scooted between Sara’s legs and into her room for safety. She picked him up, and could feel him trembling…

    Hugging Scruffy close to her, Sara withdrew back into her room and ever-so-quietly closed the door.

    Quiet Distractions Provide Solace

    She set up a tea party in her closet where it would be extra quiet… and brought in Baby Alive and Jenna to share it with her.  hmmm….we need one more, she thought.  She reached under her bed and pulled out Timothy, her cream-colored teddy bear…and took him into the “tea room” in her closet floor. With the light turned on, she pulled her closet door shut.

    Shame Torments

    Ben had stopped sobbing by now…and was looking at his feet. It’s never going to stop, he thought.  What’s wrong with me?? I always ruin everything. I’m the black sheep of this family.

    Why can’t I be like everyone else…?  I’m so worthless, stupid, bad, and rotten to the core. I should never have been born… I’ll probably end up being a criminal…

    “Whatcha thinking, Ben?” Ben’s mom waited patiently for Ben to gather his thoughts.

    While Ben was searching for words, the front door opened. 

    Learning to Support Each Other In the Family

    His dad was home from work. Ben tried to look pleasant.

    “Hi Dad…”

    “What’s going on…?  Has something happened…?” Ben’s dad spotted the bashed windows and looked worried. Then his eyes fell on Ben’s swollen red face. Ben felt humiliated and didn’t know what to say.

    “Hi Bill.  How was your day?”  Ben’s mom hated to bombard him with the latest family crisis when he’d just walked in from a stressful day. And she also hoped to give Ben a break from his dad’s scrutiny.

    “It was fine, Lil. Is everything ok?”  

    The air in the room hung heavy with tension. But they were a family, and they needed to face times like these together, so Lily spoke up.

    “Everything’s fine, honey. Ben had another episode today. It was terrible for him…well, for all of us. He’s feeling pretty discouraged right now. We were talking about what we could do to find a doctor that might help more than Dr. Mendolssohn has. Someone maybe who specializes in adolescent bipolar disorder?”

    Ben focused on the pet hair on the rug. Bill nodded and stared at his feet, hands in his pockets. Lily stroked the sofa cushion. When a family is suffering together with psychiatric disorders…well, each one harbors his own secret pain.

    A big part of that pain is helplessness.

    This young man is angry because his family is suffering together with psychiatric disorders and he feels helpless.

    Bill spoke first. “I noticed the car is gone…did Gregory leave?”  

    Ben sighed.  Lily nodded.

    “And Sara…?”

    The NON-Squeaky Wheel Needs Attention, Too

    Lily sprang up from the sofa and headed for Sara’s room.  Her little girl had been so quiet…and with all the turmoil, she forgot to check on her. Guilt swelled up and threatened to choke her.

    Tap, tap, tap.  “Sara? May I come in please?”  Lily tried to sound cheerful.

    Tap-Tap-Tap. “Sara?”

    Lily opened the door and didn’t see Sara.  

    “Sara??”

    A tiny muffled voice squeaked, “yes, Mom?”

    Lily got down on her knees and looked under the bed. Nothing.

    She looked on the other side of Sara’s bed. Nothing but a couple stuffed animals.  

    “Sara? Where are you?”

    The closet door opened. Sara’s hair was disheveled and the rims of her eyes were red. She’d been crying.  Lily rushed over to her and swooped her up in a hug.  

    “Whatcha doing in your closet..?”

    “Tea party…”

    “Wanna help me cook supper?”

    “Yeah!”  

    She swung Sara onto her hip and off they went to the kitchen, chattering about the tea party.

    With Psychiatric Disorders, Symptoms Can Look Like Bad Behavior

    Ben is walking alone to sort his thoughts because his family is suffering together with psychiatric disorders.

    Bill was sitting with Ben, helping him with his algebra homework.  He knew a lecture about behavior wasn’t what Ben needed. He needed acceptance and support. Bill had made plenty of mistakes while he learned how to provide what his family needed in times like this.

    So.

    Another day. Once again they’d survived another major bump in the road. Tomorrow they’d call the insurance company about the damaged windows. But for now, they were thankful for peace.

    He and Lily did their best to try to help Ben’s self-image remain strong…though they knew all too well that their best efforts might not be enough. They also tried to be sure Gregory had their time, support, and attention, too. It was easy in this household to be overlooked.

    They were learning to avoid reacting with even more conflict or criticism. But rather to choose words and tone that soothed. Everyone needed it. And they believed their reactions were improving.

    Family: Suffering Together with Psychiatric Disorders

    Which brings up little Sara. They worked hard to try to protect her innocence and sweetness. But they couldn’t protect her from the frequent upheavals in her own home.

    Families suffering with psychiatric disorders work hard to keep their relationship strong.

    They also knew they had to be sure to communicate and make time for their relationship with each other. That was usually the first to be sacrificed.

    Most of the time they were both stretched pretty thin.

    Breathe.

    Got anyone in your family with a psychiatric condition?  It might be an eating disorder, bipolar disorder, severe depression, social anxiety (yes…that’s a disorder too), addiction, PTSD… there are lots of possibilities.

    No matter what the condition, and whether it’s you or someone else, a family with a psychiatric disorder suffers together, feels helpless together, gets frustrated together… no one escapes.

    And while it’s easy to blame, that doesn’t accomplish much, does it?  It just makes the wounds infect.

    When it gets right down to it, there is likely some genetic connection that links you all to the disorder. In this family, Ben drew the short straw.  And bears the stigma. 

    But just as Bill isn’t to blame for the high blood pressure he inherited from his grandmother, and Lily isn’t to blame for her kidney stones, Ben inherited the tendency to develop his condition before he was ever born.

    To try to manage his blood pressure, Bill either jogs or takes a brisk walk every night after work while Lily cooks dinner. Lily is careful to stay hydrated to avoid more stones. Ben tries to get out and play football in the afternoons and they work together to see that he eats balanced meals and gets to bed early. And they all take medication for these health problems.

    When The Brain is Disordered, It Can Be Hard to Maintain Order At All

    Not just for the person with the condition, but everyone close to him, too.

    So don’t be fooled. The family tries to maintain these routines, but that’s not as easy as it sounds. It takes a concerted effort, and they try to support each other and understand when things don’t go as planned. Because, when a family is suffering together with psychiatric disorders, everything is more complicated, it seems.

    Families like this have plenty of bad days.  More days than they care to admit actually… where all the opportunities to manage their collective health slip through their fingers.

    But they do try. And when things fall apart, they help each other get up and try again. Or at least they try to. Sometimes everyone just gets sick and tired of it all. So they retreat into their corners to recover a bit, then come together and face their life together again. At least that’s their intention.

    Life Is Challenging on Some Level for Us All

    If you don’t have a person in your family who has a health condition, maybe things go smoothly for you…?  But I bet they don’t go as smoothly as you wish. Nobody’s life is perfect.

    Still, if you do have one or more family members who endure chronic illness, (the genetics often strike multiple times in a family) you probably feel like no one can imagine what it’s like. You likely feel isolated and alone. Maybe you feel embarrassed, because your life isn’t perfect. And you’re right to some degree. No one knows what it’s like to live your life. But you don’t know what it’s like to live someone else’s either.

    I can say this however… that if your family suffers with a member who has a brain or behavior disorder, we know it impacts the whole family. And our hearts are with you.

    Is Your Outpost Suffering Together with Psychiatric Disorders?

    Family is our most important outpost of support. No matter what the challenges a family faces, they don’t manage them well all the time.  In fact, it’s fair to say there are LOTS of times the whole family seems to implode.

    Some families have financial struggles. Other families have marriage struggles. And still other families have health struggles.  But whatever the challenges, pulling together is the best way for everyone to come out in the best shape possible.

    But then, that’s life, isn’t it?

    It’s for you we work at Innovative Psychiatry to find better solutions, more effective treatments, and the compassion and support you need. And we’ve found extraordinary results for families like yours with ketamine treatment. You may have a family member with bipolar disorder, major depression, or PTSD. If so, call us.

    She just might be a candidate for IV ketamine treatment. That also goes for social anxiety, addictions…and of course suicidal thoughts. ALWAYS take suicidal thoughts seriously. And let us help.

    But don’t forget to take note of other family members who may be suffering in addition. They may need treatment, too, so they have the energy to conquer the days, weeks, and months of stress at home.

    There is help available for your family. To feel better, with restored hope, and more harmony.

    Lori Calabrese, MD offers innovative psychiatric treatment like IV Ketamine

    To the fresh emergence of your best selves,

    Lori Calabrese, M.D.

  • How the Biology of Suicide  Illuminates Prevention

    How the Biology of Suicide Illuminates Prevention

    The biology of suicide shows us to prevent suicide with ketamine treatment.

    When someone commits suicide, you’ll sometimes hear people say, “It makes no sense! She had everything to live for…” Or, “What a selfish thing to do. What about all the people who loved him? What about his kids…his wife..?” But this sort of tragedy isn’t about selfishness. To grasp what happens with your suicidal loved one, we are beginning to understand that there is a biology of suicide, and it can play into whether or not someone takes her life. It also helps to know what can be done. Read one young woman’s story to see what I mean…

    …Casey climbed the stairs and disappeared into the darkness of her room without flicking on the light. Somehow the darkness was more comfortable. More familiar. She dropped her keys on the hall tree and her purse and coat on the floor, then flopped onto the sofa.

    Settling back, her neck resting on the back cushion, she stared blankly at the ceiling. Another day was behind her. 

    It was always a feat to survive another day of work. Miserable. Now that she had, her mind wandered to nothingness. The billowing relief that would come if she could just get off this ride…this miserable journey day in and day out… Casey lost herself in reverie thinking about what a relief that would be.

    She couldn’t do it anymore. She just couldn’t. And…she wouldn’t.

    No one in Casey’s life had any idea what she goes through. She seemed astute, responsible, reliable to those around her. Quiet. Sometimes a little short-tempered… But pretty self-sufficient.

    The darkness wrapped itself around her, and she hung her head in exhaustion.

    Random thoughts drifted through her mind. The summer she was 3. She had climbed a tree and went too high.  As she looked down she felt a little lightheaded and swayed in the branch as the wind blew. She had thought that if she just jumped, she would go to heaven. 

    “Good grief,” she thought. “I was only 3 then. Was there ever a day in my life I didn’t think about dying? Wish I could die? Figure out how to die…??”

    She closed her eyes. “Thirty one years. I guess it will go on as long as I live…”  Then, she thought, but why? What’s the purpose of my life beyond dreading, thinking about dying, seeing only futility..?”

    “Why put it off any longer..?”

    And then, something happened.

    She opened the drawer in her nightstand, reached to the back, and pulled out a tin of pills she’d been saving for years. The prescription said TWO pills.  And she’d taken one and stashed one. There was another bottle she’d squirreled away in her closet, so she felt around till she found it and tossed it on the sofa. 

    After a bit she dragged herself into the kitchen, and pulled the Kentucky Honey Whiskey from the cupboard a friend had left at her house 6 months ago. As she reached up for it, she saw the Tylenol and grabbed it.

    She knew that too much Tylenol would damage the liver, so slipped that into her pocket. The whiskey bottle was three-quarters full. That will help, she told herself. Then she grabbed a glass and took the bottle to the coffee table. 

    With all she would need in place…she lay down and drifted off to sleep…

    Honking from the street below. HONK HONK HONK!! Wondering about the time, she looked at her watch. 11:49.  Just a few minutes before midnight.  

    Methodically, she poured Kentucky Honey into her glass and chased the first few pills. Then poured another glass, and swallowed 4 or 5 more. 

    Pain pills and sleeping pills… hmmmmmm…    It seems to me I should feel a little different by now.  She was glad for the late hour. Unlikely anyone would find her too soon. No one ever knocks or stops by.

    She popped more pills into her mouth.

    The Kentucky Honey was becoming harder and harder to swallow. Her head was spinning from the glasses of it she’d had so far.

    All she could think about was the relief she would feel when this was over…

    This lady sank as she wondered about her worth and her purpose in life.

    No one had any idea…she had always held her feelings and frame of mind close to the vest. Impossible to get her to talk, really…

    We do so much research about what drives someone to suicide. But what actually happens– biologically?

    Why Now? Why Tonight ?

    Some people think about suicide every day of their lives and never act on it. What’s behind the moment someone actually takes the step to end his life? And what role does biology — the biology of suicide — play?

    Two prominent researchers are known for their insightful hypothesis about this way back in the 1990’s. Their contemporaries swore by the prevailing belief that depression was caused by low levels of the neurotransmitter serotonin. (You remember those days?) These two were burning the midnight oil trying to figure out HOW that was true.

    Their names were Charney and Krystal. Dennis Charney is now the Dean of Icahn School of Medicine at Mount Sinai in New York. He was focused on depression. John Krystal was exploring schizophrenia to better understand and treat it. 

    In both cases, their work at Yale at the time led them to glutamate, the most prolific neurotransmitter in the human body. As an excitatory neurotransmitter, glutamate helps brain cells communicate, so it’s critical in learning, memory development, mood and …. the list goes on.

    So they went to work together to learn what they could.

    Now, you need to understand that at that time, even though ketamine was a solid and relied-upon anesthesia medicine, its dark reputation as an abused substance in the club scene — and on the street — kept it from getting much attention in research.

    Glutamate Paves the Way to Ketamine

    Ketamine causes specific behaviors in people who use it on the street, usually within 2 hours after taking it. But the amount they ingest is around 100 times greater than the doses used in anesthesia, or the even smaller dose these researchers gave their subjects. 

    This is where some people get the wrong idea about ketamine. If they’ve heard about it or seen it on the street, they tend to be terrified of its use therapeutically because of severe side effects they’ve seen.

    But when ketamine is used in tiny doses therapeutically, it’s a completely different “animal.”

    Even so, Charney and Krystal didn’t want to miss anything that might show up later so, in an abundance of caution, they decided to monitor their research subjects for a full 72 hours after their ketamine infusion. They chose 9 subjects to try the ketamine infusion, but 2 of them dropped out. So they followed 7 depressed subjects for 72 hours. This was a turning pointKeep reading…

    This joyful guy benefitted from the biology of suicide when his doctor gave him ketamine to erase suicidal thoughts.

    Four hours after the ketamine was administered, they checked on the patients. These patients declared they felt better.  In fact, they felt a great deal better! Our researchers were shocked beyond belief. Everyone knew that antidepressants take weeks or months to produce an antidepressant effect, and this medicine produced dramatic results within 4 hours.

    They didn’t expect anyone to believe them, and kept these results under the radar for years. When they finally did publish their results in 2000, they got …. not much attention. 

    Low Serotonin Severely Alters the Brain – Which Plays into the Biology of Suicide

    But during the same time another research team, John Mann and Victoria Arango, set out to study the brains of suicide victims. Over time, they discovered that certain areas of the brain showed alterations in serotonin. A significant kind of alteration.

    In fact, this situation reminded them of the well-known story of Phineas Gage, back in 1848. Gage was a railroad worker, and had been impaled by a 43-inch cylindrical iron tamping bar right through his skull.

    Amazingly, he survived the accident, but his personality completely changed. His doctor later wrote that Gage’s “character” was altered by the damage and his “animal propensities” emerged, as he put it. He wrote that Gage was fitful and irreverent. He called him capricious and vacillating, and complained that he used the “grossest profanity.” Now Gage had been a foreman: a responsible, circumspect, hardworking man before the accident. So you see, the change was dramatic.

    It wasn’t until more modern times that research revealed the area of the brain destroyed by the iron tamping bar is the area that controls inhibitions, and in Gage’s case, his social inhibitions.

    And that’s one of the same areas affected by “low levels of serotonin transporter binding.”

    So, with low levels of serotonin, the inhibition disappears. In the cases of these suicidal victims, the researchers think the inhibition that kept them from committing suicide was lifted, and they surged forward and ended their lives.

    But again, this may have happened as a number of other social, economic, and interpersonal factors were unravelling. There are so many contributing factors to suicide. And even when we can study and pinpoint biological correlates, we know that low levels of serotonin in the cerebrospinal fluid, and probably low levels of serotonin transporter binding don’t always result in suicide.

    Of course they don’t.

    Moreover, even if the doctors of these patients had known the exact biological areas and brain processes involved in suicide, and had a way to modulate the activity there, it still might have taken weeks or months to reach a therapeutic effect — and it might not even have worked …as it may have been too late.

    Ketamine Takes Its Cue From the Biology of Suicide in YOUR Brain

    So this is a HUGE key to why ketamine treatment can be so vital to erasing suicidal thinking.  Because it can erase those thoughts in an afternoon, in the psychiatrist’s office. No need to wait weeks or months and risk suicide while you wait for it to take effect. 

    Compassion for Suicidal Loved Ones

    People who succeed in, or even attempt, suicide, aren’t thinking about the feelings of others. (There’s some truth to that…but not necessarily what the criticizers think.) Quite honestly, in that condition they can’t. They may have been induced by their disordered brain to think about suicide for a very long time, or maybe just so intensely, whether they wanted to or not. Then, if the biology of suicide kicks in and they have little or nothing to help them hold back, they may act impulsively and without recourse or consideration of consequences.

    For those of us who love them, unless we’re tormented by the same suicidal thoughts, we can’t imagine what it’s like to want to die, or to feel compelled to die.

    This isn’t selfishness…it’s sickness. It’s also not selfish when a Type 1 diabetic’s blood sugar drops so low he convulses. It’s a consequence of his serious illness.

    And it’s for this reason that it’s important to never dismiss or ignore talk of suicide.

    Thankfully, IV ketamine treatment can provide the safety stop to put on the brakes and end the suicidal thoughts.

    It can give your loved one time to heal and move forward with their lives.

    Biology of Suicide at Innovative Psychiatry

    At Innovative Psychiatry, we’ve seen so many who fought the torment of suicidal thoughts and inclinations, walk out free of those thoughts after IV ketamine treatment.

    This young man is working with a rope to end his life because of the biology of suicide.

    Many times they’ve reached the point of emergency late in the day and needed immediate treatment. Then, after ketamine treatment, found immediate relief. The biology of suicide – in those cases — is side-stepped and overcome by the most rapid and effective treatment for suicidal thinking of our time.

    We’re also flooded with relief for them as the suicidal thoughts subside, the light comes to their eyes, and they leave relaxed and eager to continue restorative treatment for their depression symptoms. 

    ***If you have suicidal thoughts a few times a week, or 20 times a day: please know that there is hope. Those thoughts can stop. Reach out immediately for support by calling the National Suicide Prevention Lifeline at 800-273-8255. OR text HOME 741741. Someone is available to listen 24 hours every day. ***

    And consider IV ketamine treatment. It can help you experience freedom from those tormenting thoughts and find hope and purpose in your life again through relief from depressive and anxious symptoms. Fast.

    This joyful woman has been transformed from suicidal thinking since ketamine treatment.

    The first step happens when your life is no longer at risk. 

    Your life really can be fulfilling, rewarding, and productive as you experience what ketamine treatment can do for you. While it’s not a one-size-fits-all treatment, IV ketamine treatment can restore your motivation and initiative, your creativity and energy, so you can invest in your relationships, your career, and your hobbies with enthusiasm and joy.

    Can we stop suicide? Yes, with a series of IV ketamine infusions.
  • Antepartum and Postpartum Anxiety: Moms Who Suffer Without Feeling Sad

    Antepartum and Postpartum Anxiety: Moms Who Suffer Without Feeling Sad

    Ketamine treatment helped this mom restore from antepartum and postpartum anxiety.

    Treatment can help anxious moms relax and enjoy their babies.

    Jill was so excited to be pregnant.  She’d waited for 4 years after she and Joe were married to start trying.  She was just elated three months later when a home pregnancy test showed those two little lines.  She was pregnant! Even the slightest thought of antepartum and postpartum anxiety never crossed her mind.

    In spite of waves of nausea off and on the first couple months, by the time she got through her first trimester, she was feeling better.  Her excitement to see and hold her precious baby was bubbling up like crazy. How could she wait six more months??

    But as she moved through the 4th month, she began to feel… uneasy.  

    Just this vague sense that something bad could really happen… maybe something about her pregnancy wasn’t going as it should? She worried that something was going wrong with the baby. What if there was something wrong that they couldn’t see? Or a problem with his development?  What if he was in that 3%? What if something went really wrong during delivery?How would she take care of him?  

    Day by day the dread grew worse. She asked her doctor about her concern, and she assured her that everything looked good. Told her that she should enjoy her pregnancy.

    That was the problem. She couldn’t. She was worried sick.

    Then, when she reached her third trimester, the dreams started with a vengeance. Night after night she’d dream she gave birth … to an alien.  Or a forest creature.  Or a monstrous murderous demon. She was so ashamed that these were her nightmares that she couldn’t tell anyone. No one.

    When something is so terrible, who can you tell? Who can you trust?

    The nightmares were so cruel, so vivid, that she’d wake up in the wee hours sweating, heart pounding, and screaming. Her husband would try to comfort her, then she’d go back to sleep. And the nightmare would continue. It was as if she couldn’t escape. 

    By the time the baby was born, her joy was gone, and in its place loomed a terrible dread. She feared for the baby, and what he would grow to be.  Not who…but what.  She tried to nurse him in the hospital but would break down and cry and ask the nurses to take him for awhile to give her a break.

    Going Home From the Hospital Didn’t Help

    It wasn’t supposed to be like this!  What was happening to her?  Why couldn’t she enjoy her newborn son?

    The first 6 weeks or so she tried. She really tried. She was exhausted, and wondered if she’d ever get enough sleep to feel better. Waking every hour or two around the clock took a toll she didn’t anticipate. Her thoughts about her baby seemed irrational, even to her. She couldn’t imagine why she ever thought she wanted a baby.  Now here she was, stuck in a permanent nightmare. She felt cheated.

    Then her worries about what she might do to him if she let her guard down overwhelmed her.  She mentioned her concerns to her pediatrician during a routine visit, and he explained that this could be postpartum anxiety and gave her a card to see someone he trusted.

    Within a few months after her treatment began, she was beginning to see life, her son, and herself in a new light. She could sort of imagine now that it was possible she could have a good and loving relationship with him. 

    It helped enormously to know all this was a condition her hormonal imbalances and stress created. To fully realize that neither she nor her infant son were to blame. She read all she could find on antepartum and postpartum anxiety.

    There wasn’t much.

    But where, oh where, did it come from?

    We’re all familiar with postpartum depression, but you rarely hear people talk about postpartum anxiety. While the two often join forces, they’re actually individual disorders.  Since postpartum depression is often associated with sadness and anxiety, postpartum anxiety is sometimes overlooked.

    It’s actually possible to feel overwhelmed, severely stressed, and have thoughts of harming your baby or… of ending your own lifewithout feeling sad.

    When a woman gives birth, several changes go into high gear in her body. Pregnancy hormones drop, lactating hormones kick in, and the sudden changes in her brain give way to mood swings.  

    This woman suffers from antepartum and postpartum anxiety and needs treatment to feel relief and to bond with her baby.
    Add to that the painful engorgement in her breasts as milk comes in, lack of sleep from her baby’s waking every hour or two to eat, the soreness in her perineum from stitches, (or in her abdomen from a C-section) and cramping of her uterus as it recovers from pregnancy and childbirth, and this new mother is enduring substantial stress.

    Stress + Fear = Anxiety

    Even though many people are more familiar with postpartum depression, roughly 6% of all pregnant women and about 10% of those who are postpartum develop anxiety that’s severe enough to need treatment.

    It’s natural for a new mother to have mild worries or nervousness about whether her baby is eating enough, whether the baby’s stool is like it’s supposed to be…and wonder if she’ll ever feel rested again.

    But when mild worries become more intense, concern becomes a constant dread that something bad is going to happen, or intrusive thoughts begin of harming the baby or yourself, it’s time to seek help.

    So why do some mothers seem to adapt to the new addition to the family, along with hormone changes, the lack of sleep, and the new routine, while others feel and think things they don’t want to feel or think, struggle to bond with the baby or enjoy her, and wish for a way to escape … either temporarily or permanently…?

    There are a number of factors. And none of them are the anxious mother’s fault. 

    Risk Factors for Antepartum and Postpartum Anxiety

    First, mothers who have relatives with anxiety disorders –or have had anxiety disorders themselves in the past — are at higher risk for postpartum anxiety than woman with no family history of anxiety at all. In addition, women with thyroid imbalance are at higher risk, also. 

    Most of the time when we refer to postpartum anxiety, we’re talking about a generalized anxiety disorder that develops during or after pregnancy. Symptoms like nervousness, constant worry, difficulty sleeping, racing thoughts, tension…

    But there are a couple more types of postpartum anxiety that are important to highlight.

    Postpartum Panic Disorder

    Panic disorder doesn’t mean being panicky, or having anxiety that escalates easily until you feel wound up. It means having frank, out of the blue, and unprovoked panic attacks. You’re not just worried all the time about whether the baby is eating enough, whether you’re capable of being a good mother, or whether the baby will get sick, you begin to get random episodes of sheer panic.

    Sometimes multiple times a day.

    Shortness of breath, fast heart rate, chest pain, dizziness, and tingling along with feeling confined or like you’re suffocating can make it extremely difficult for you to take care of your baby, yourself, or the rest of the family. These sensations can come and go, but you may need professional help to cope with them and reduce their impact on you and your new family. 

    Postpartum Obsessive Compulsive Disorder (POCD)

    Symptoms of OCD can emerge during or after pregnancy, too. They’re similar to general symptoms of OCD but tend to be focused on the baby. Intrusive thoughts  about harm coming to your baby can crowd your mind, and even shock you.

    The next thing you know, you find yourself checking things over and over and repeating things over and over to try to avoid a circumstance that would allow your thought to come true. 

    And…you’re probably horrified at the thoughts that pop into your mind. But this is why we call them “intrusive” thoughts. They intrude into your thoughts without you inviting them.

    They’re a result of disordered circuitry, and misfiring signals, in your brain as the result of relentless and overwhelming stress, shock, and genetics.

    Of all of the antepartum and postpartum anxiety disorders, this may be the most difficult and the most upsetting of all. Even though you probably know in your head you would never follow through on the thoughts, and you also know that the repetitions and cycles of checking don’t really help, you probably feel powerless to stop. But treatment can do what you can’t by yourself.

    Because this condition is treatable, and you need to not endure these symptoms alone. Seek help and treatment so you can get your life and your relationship with your child back on track and in a healthier, brighter place.

    Postpartum anxiety disorders are not your fault.

    You’re not to blame for the intrusive thoughts, the fears, the compulsive reactions. These are a result of your genetics, your circumstances, your stress, and your family history. But treatment is not only available to you, it also can return your world back to its right and rewarding function.

    Antepartum and postpartum anxiety disorders come in various forms with a variety of faces.  But it’s vital that you not confront this alone. Rather, seek treatment. And please know that this is not your fault. Even so, you may not get better without help outside yourself. 

    Treatment for antepartum and postpartum anxiety is vital so mom and baby can bond and enjoy each other.

    If you’re pregnant and feeling feelings and thinking thoughts that aren’t what you wish you they were, there is help available. If your baby has been born, and those feelings are just starting or are getting worse, call us. We can help you feel better, or refer you to someone who can.

    Don’t face postpartum anxiety disorders alone.  

    You and your baby deserve a loving and happy relationship together. 

    Can we stop suicide? Yes, with a series of IV ketamine infusions.
  • Ketamine Restores Brain Circuitry Damaged by Depression – FAST

    Ketamine Restores Brain Circuitry Damaged by Depression – FAST

    Ketamine restores brain circuitry to bring joy to depressed people.

    In a world where things go wrong and people get sick, every once in awhile something comes along that makes things right again. I’m talking about something that’s so dramatic in its solutions we’re tempted to call it a “miracle.” 

    But we won’t.

    We’ll call it a game-changer.

    Because IV ketamine treatment is changing history.

    Nothing elicits our excitement like a tool that helps people to the degree this one does. So many people with complex co-morbid psychiatric disorders drop their shackles of symptoms …and discover they’re free to live rewarding lives.

    IV Ketamine Restores Brain Circuitry

    Ketamine does exactly that in the vast majority of those who were before hopeless in their condition. People whose severe illnesses prevented them from working, from building relationships, from enjoying anything. People whose lives were at risk because symptoms like suicidal thinking were made worse by their own despair.

    The World Health Organization (WHO) declares depression and other severe mood disorders the leading cause of disability throughout the world. And yet, until the last several years, at least a third of these people could not be helped.

    But, in the last decade, an often-abused anesthetic has emerged as a game-changer that millions were searching for.

    Ketamine — so safe and effective that the WHO lists it as one of its 10 essential medicines — is now rising as one of most effective and extraordinarily restorative treatments we’ve ever had.

    But to be clear — and to be fair — there are still some who don’t benefit. We continue to watch for more research that helps us understand why. And to look for and learn ways to possibly help them and more.

    New Study Throws Open the Shutters on Synapse Restoration

    Conor Liston, M.D., Ph.D

    A study just released this month by Conor Liston of Weill Cornell Medicine, and colleagues, revealed yet more than we knew before about how ketamine works to achieve this remarkable restoration.

    Dr. Liston is a leading researcher in the field of circuitry specific to the prefrontal cortex and its impact on cognitive and emotional processes. It’s the dedication of researchers like Dr. Liston, and a host of others, that has helped us understand and use the benefits of ketamine for our patients. We never take our neuroscience researchers for granted.

    The combined effort of research teams like Dr. Liston’s in the U.S. and Tokyo resulted in expanded understanding of just what happens when ketamine reaches the brain in someone who’s stressed and depressed.

    Of course their work is performed in the laboratory with lab animals, but gives insight about what happens in the brains of people, and how ketamine restores brain circuitry for them. Insights like this are changing the course of psychiatric treatment.

    Ketamine’s Active Role with Neurons and Dendrites

    The researchers used a “cutting-edge” technology that included light microscopes and allowed them to view the tiny dendrites and dendritic spines of synapses (in the medial prefrontal cortex) over time, so they could see what happens there over several hours, and then what happens after more than a day.

    It turned out that the neuronal circuits changed first, with a readily observable change in behavior, in the initial 3 hours after ketamine. (Hold that thought: the circuit activity changes first.)

    Then, over the next 12-24 hours, they saw that the number of spines had increased by well over half of those that had been lost during stress.

    So they realized that the new spines and synapses were the result of the improved circuit activity. 

    Extraordinary.

    New Technology Opens New Doors

    This is the first time we’ve had an inkling into the timing of the effects and repair instigated by ketamine. The improvement seems to be a one-two punch. Once the spines survive a few days, they form new connections, and then within another 2-7 days, improved behavior and function became apparent.

    This brand new discovery of ketamine’s effects helps us understand that there can be an immediate response to ketamine, and then a longer lasting reversal of symptoms that occurs a little later.

    Both of these functions are important.

    Old Treatment Replaced by New Insights

    Remember that the old premise for treating depression was to increase the availability of neurotransmitters like serotonin to improve the movement of signals in the brain. For some people this was enough to help relieve the depression.

    This weeping woman needs to know ketamine restores brain circuitry and lifts depression.

    But in too many others, it did very little to relieve anything. We know now that stress prunes the signaling structures themselves. Stress from life, illness — whateverbreaks down, weakens, and destroys the synapses. The dendrites, dendritic spines, and synapses that are the highways the signals travel must be rebuilt.  Without these structures, neurotransmitters like serotonin, dopamine, and norepinephrine can’t do their job.

    Ketamine comes along and reverses this destructive process. It repairs damaged circuits, rebuilds new dendritic spines and synapses, increases connections, and lubricates signals with neurotransmitters … in the medial prefrontal cortex and in other key parts of the brain, too.

    This revelation about how ketamine restores brain circuitry will most likely contribute to the ongoing development of new psychiatric drugs. We’re excited about the possibility that new medications can be designed to do all of this before they’re used by physicians for our patients.

    Getting Closer to Bigger Breakthroughs

    So we have a new paradigm, a new pattern to build upon. We may see over 80% response in patients with ketamine now, but we’re shooting for the time when researchers can improve upon this across the board… to be able to truly relieve psychiatric suffering — hopefully in our lifetime.

    And we keep getting closer.

    The Modes of Response Vary

    As it stands now, there are some people who are so responsive to ketamine treatment that they feel remarkably better after the first infusion, and with each treatment, they become more and more hopeful, brighter, more joyful, more creative, and more resilient.

    There are others who sense nothing for 3 or more infusions, then finally experience improvement, relief, and eventually joy just like the first group. These may require a few more than six infusions to reach that point.

    woman wearing blue denim jacket standing in front of white concrete buildings

    Then there are those who may have 8 or 9 infusions. They may experience a few days of improvement throughout the process, but seem to keep losing the beneficial effects. In those cases, we explore other body systems and serum levels to find areas that need to be treated so the “treatment-resistance” can be penetrated, then with another infusion or two they finally achieve the same joy and resilience. We call it remission. And we fight for it.

    Still, of course, there remains that small group who don’t seem to improve, so we continue to press on, to explore reasons…and possible solutions.

    Science …and ART

    IV ketamine treatment is the most remarkable treatment for mood disorders we’ve seen. And clinicians and researchers are looking beyond “mood disorders” all the time. Addictions and substance use disorders, for example, were considered to be disorders of motivated behaviors and treatment focused on teaching behavior control. We’ve learned so much, and while treating these disorders is complex, we’re finding IV ketamine can play a dramatic role in reducing craving and contributing to abstinence. “Dramatic” is an understatement.

    Overall, the administration of IV ketamine treatment is both a science and an art. 

    Ketamine Treatment is a Process Toward Restoration

    At Innovative Psychiatry in South Windsor, CT we encourage our patients to have patience with the process. To hold a commitment to see it through to fulfillment. And to consider a “booster” infusion if benefits subside or fade — whether it’s once every year or two, or twice a year…or every 3-4 months, if necessary.
    woman wearing black V-neck T-shirt during daytime

    Because every brain is different, and every life has its own unique character and pitfalls. It may be necessary to build and improve the infrastructure in your life. To accept yourself and others as they are, and learn to embrace the joys of life and ignore the stressors. All of this can help strengthen your remission and help it last longer.

    If you’ve suffered the symptoms of a disorder without relief from treatments or medications, call us.

    We’re committed to your restoration and eventual joy.

    To the rediscovery of your best self,

    Lori Calabrese, MD offers innovative psychiatric treatment like IV Ketamine
    signature of Lori Calabrese, M.D.
    Lori Calabrese, M.D.

  • Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain

    Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain

    The anesthetic-cum-party drug restores the ability to make connections among brain cells. The Food and Drug Administration’s approval last month of a depression treatment based on ketamine generated headlines, in part, because the drug represents a completely new approach for dealing with a condition the World Health Organisation has labelled the leading cause of disability worldwide. The FDA’s approval marks the first genuinely new type of psychiatric drug—for any condition—to be brought to market in more than 30 years.

    Although better known as a party drug, the anesthetic ketamine has spurred excitement in psychiatry for almost 20 years, since researchers first showed that it alleviated depression in a matter of hours. The rapid reversal of symptoms contrasted sharply with the existing set of antidepressants, which take weeks to begin working. Subsequent studies have shown ketamine works for patients who have failed to respond to multiple other treatments, and so are deemed “treatment-resistant.”

    Despite this excitement, researchers still don’t know exactly how ketamine exerts its effects. A leading theory proposes that it stimulates regrowth of synapses (connections between neurons), effectively rewiring the brain. Researchers have seen these effects in animals’ brains, but the exact details and timing are elusive.

    new study, from a team led by neuroscientist and psychiatrist Conor Liston at Weill Cornell Medicine, has confirmed that synapse growth is involved, but not in the way many researchers were expecting. Using cutting-edge technology to visualize and manipulate the brains of stressed mice, the study reveals how ketamine first induces changes in brain circuit function, improving “depressed” mice’s behavior within three hours, and only later stimulating regrowth of synapses.

    As well as shedding new light on the biology underlying depression, the work suggests new avenues for exploring how to sustain antidepressant effects over the long term. “It’s a remarkable engineering feat, where they were able to visualize changes in neural circuits over time, corresponding with behavioral effects of ketamine,” says Carlos Zarate, chief of the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health, who was not involved in the study. “This work will likely set a path for what treatments should be doing before we move them into the clinic.”

    Another reason ketamine has researchers excited is that it works differently than existing antidepressants. Rather than affecting one of the “monoamine” neurotransmitters (serotonin, norepinephrine, and dopamine), as standard antidepressants do, it acts on glutamate, the most common chemical messenger in the brain. Glutamate plays an important role in the changes synapses undergo in response to experiences that underlie learning and memory. That is why researchers suspected such “neuroplasticity” would lie at the heart of ketamine’s antidepressant effects.

    Ketamine’s main drawback is its side effects, which include out-of-body experiences, addiction and bladder problems. It is also not a “cure.” The majority of recipients who have severe, difficult-to-treat depression will ultimately relapse. A course of multiple doses typically wears off within a few weeks to months. Little is known about the biology underlying depressive states, remission and relapse. “A big question in the field concerns the mechanisms that mediate transitions between depression states over time,” Liston says. “We were trying to get a better handle on that in the hopes we might be able to figure out better ways of preventing depression and sustaining recovery.”

    Chronic stress depletes synapses in certain brain regions, notably the medial prefrontal cortex (mPFC), an area implicated in multiple aspects of depression. Mice subjected to stress display depression-like behaviors, and with antidepressant treatment, they often improve. In the new study, the researchers used light microscopes to observe tiny structures called spines located on dendrites (a neuron’s “input” wires) in the mPFC of stressed mice. Spines play a key role because they form synapses if they survive for more than a few days.

    For the experiment, some mice became stressed when repeatedly restrained, others became so after they were administered the stress hormone corticosterone. “That’s a strength of this study,” says neuroscientist Anna Beyeler, of the University of Bordeaux, France, who was not involved in the work, but wrote an accompanying commentary article in Science. “If you’re able to observe the same effects in two different models, this really strengthens the findings.” The team first observed the effects of subjecting mice to stress for 21 days, confirming that this resulted in lost spines. The losses were not random, but clustered on certain dendrite branches, suggesting the damage targets specific brain circuits.

    The researchers then looked a day after administering ketamine and found that the number of spines increased. Just over half appeared in the same location as spines that were previously lost, suggesting a partial reversal of stress-induced damage. Depression-like behaviors caused by the stress also improved. The team measured brain circuit function in the mPFC, also impaired by stress, by calculating the degree to which activity in cells was coordinated, a measure researchers term “functional connectivity.” This too improved with ketamine.

    When the team looked closely at the timing of all this, they found that improvements in behavior and circuit function both occurred within three hours, but new spines were not seen until 12 to 24 hours after treatment. This suggests that the formation of new synapses is a consequence, rather than cause, of improved circuit function. Yet they also saw that mice who regrew more spines after treatment performed better two to seven days later. “These findings suggest that increased ensemble activity contributes to the rapid effects of ketamine, while increased spine formation contributes to the sustained antidepressant actions of ketamine,” says neuroscientist Ronald Duman, of the Yale School of Medicine, who was not involved in the study. Although the molecular details of what happens in the first hours are not yet fully understood, it seems a restoration of coordinated circuit activity occurs first; this is then entrenched by neuroplasticity effects in synapses, which then maintain behavioral benefits over time.

    [To prove that new synapses were a cause of antidepressant effects, rather than just coinciding with the improved behaviors, the team used a newly developed optogenetic technique, which allowed them to eliminate newly formed spines using light. Optogenetics works by introducing viruses that genetically target cells, causing them to produce light-sensitive proteins. In this case, the protein is expressed in newly formed synapses, and exposure to blue light causes the synapse to collapse. The researchers found that eliminating newly formed synapses in ketamine-treated mice abolished some of the drug’s positive effects, two days after treatment, confirming that new synapses are needed to maintain benefits. “Many mechanisms are surely involved in determining why some people relapse and some don’t,” Liston says, ” but we think our work shows that one of those involves the durability of these new synapses that form.”

    And Liston adds: “Our findings open up new avenues for research, suggesting that interventions aimed at enhancing the survival of these new synapses might be useful for extending ketamine’s antidepressant effects.” The implication is that targeting newly formed spines might be useful for maintaining remission after ketamine treatment. “This is a great question and one the field has been considering,” Duman says. “This could include other drugs that target stabilization of spines, or behavioral therapies designed to engage the new synapses and circuits, thereby strengthening them.”

    The study used three behavioral tests: one involving exploration, a second a struggle to escape, and a third an assessment of how keen the mice are on a sugar solution. This last test is designed to measure anhedonia—a symptom of depression in which the ability to experience pleasure is lost. This test was unaffected by deleting newly formed spines, suggesting that the formation of new synapses in the mPFC is important for some symptoms, such as apathy, but not others (anhedonia)—and that different aspects of depression involve a variety of brain circuits.

    These results could relate to a study published last year that found activity in another brain region, the lateral habenula, is crucially involved in anhedonia, and injecting ketamine directly into this region improves anhedonia-related behavior in mice. “We’re slowly identifying specific regions associated with specific behaviors,” Beyeler says. “The factors leading to depression might be different depending on the individual, so these different models might provide information regarding the causes of depression.”

    One caveat is that the study looked at only a single dose, rather than the multiple doses involved in a course of human treatment, Zarate says. After weeks of repeated treatments, might the spines remain, despite a relapse, or might they dwindle, despite the mice still doing well? “Ongoing effects with repeated administration, we don’t know,” Zarate says. “Some of that work will start taking off now, and we’ll learn a lot more.” Of course, the main caution is that stressed mice are quite far from humans with depression. “There’s no real way to measure synaptic plasticity in people, so it’s going to be hard to confirm these findings in humans,” Beyeler says.

    [Read the Original Article]

  • Ketamine: Dissociation Quality Determines Remission

    Ketamine: Dissociation Quality Determines Remission

    Dissociation quality determines remission for this man.

    Transformative remission is inextricably linked to the quality, depth, and degree of dissociation during ketamine infusions.

    Christopher trudged through the day, listless. He felt dead inside. Just couldn’t work up a care about what happened at the job interview. But practicality — the bills were piling up — drove him to go anyway.

    He did his best in the interview, then got in the car to hurry home where he could retreat into his dark bedroom and sleep. He thought about death…about ways of ending his life… of making a plan that would work, before he could be interrupted. He knew he wouldn’t do it. But he’d been living with these thoughts all his life, and in the bad times it was the only way he could calm his mind and maybe fall asleep.

    After months of research with studies she found online, his wife had been talking to him about ketamine treatment, and how it could not only wash away the suicidal thoughts but could help him feel good again, and find the energy to live. To care.

    He wasn’t buying it. Just another antidepressant. They don’t work and never have. One more way to throw away money. A waste.

    Still, she insisted, and he resigned himself to be a “guinea pig.”

    How Dissociation Quality Determines Remission Lasting Power

    The first two infusions were pleasant. Relaxing. Sort of “billowy.” But once each one ended he was back in the real world –, irritable, edgy, resigned. He thought to himself that surely his wife will now accept there’s nothing that will work, and leave him alone about it.

    Dissociation is key to transformative remission so be like this woman, and get treatment.

    His wife, however, was determined. If ketamine could help others achieve remission, then it could help her husband.

    When the doctor came in, she told him in no uncertain terms that nothing good was happening to Chris that she could see. She pressed the doctor to change something so this would not be a waste of money…and hope… Because his hope was gone. He needed success.

    Increasing the Dose and Duration

    The doctor agreed and increased the dose and extended the duration of the infusion to try to find that sweet spot between relaxation and overstimulation. Christopher’s “relaxing” experience was quite different this time.

    Little by little, he lost his awareness of his chair, his presence in the room, and of his wife sitting nearby. He felt himself floating into another room…then another place…and then he lost awareness of himself and just let his mind float, and fly, and feel freedom. He didn’t care what was happening. Christopher thoroughly enjoyed the respite and relief of this vacation from his pain.

    After his treatment ended, Chris felt a tinge of renewal. Of refreshing. Just a tinge…but it was unmistakable from the previous infusions where he soon returned to the same despair.

    Now I get it, he thought. I see where this is trying to go. He set about googling and reading to find out how to prepare himself for the next infusion, to give it its best chance. He also picked back up a low stress hobby he’d enjoyed in the past and found he was enjoying it again. Did he feel happy?  No. But there was something different.

    Just a tinge of hope.

    Christopher talked to the doctor about the first two infusions, who suggested that they keep doing infusions for awhile to make up for the lost ones. The doctor was willing to see where it took Chris, since he admitted he was learning what ketamine could do, too…

    Dissociation quality determines remission power, like with this man singing in a field.

    The 4th, 5th, 6th, 7th, and 8th infusions each enfolded Christopher in a deeper, more intense, and longer lasting dissociative experience then the one before.

    By the end of the 8th infusion and for the weeks that followed, Christopher discovered life with a fresh new perspective.

    He saw everything through more hopeful, optimistic goggles, and found more energy to create wondrous software programs in his work, enjoyed his wife like he never had before, and took up painting sunsets in a quest to truly capture the intensity of colors he saw.

    Christopher has been enjoying his life and living it with gusto for the last 13 months since his ketamine treatment. He still looks back with gratitude on that day when his wife pressed him to let the doctor raise the dose, and the transformation with ketamine began…

    In another blog, we discussed the role dissociation plays in remission from depression symptoms.

    Let’s talk more about what that dissociation can be like.

    Dissociation Quality Determines Remission Power

    Since this last article about dissociation was written last fall, the field of ketamine for treatment resistant depression and other psychiatric disorders has grown by leaps and bounds. You can sample some of the reasons why here, here, and here.

    Physicians, researchers, pharmacologists, and biochemists are in high gear exploring, testing, adapting, and learning at such a clip it’s hard to keep up.

    But with so many brilliant neuroscientists constantly studying ketamine treatment — and so many dedicated physicians learning more and applying the new information to their patients’ treatments — growth was bound to happen.

    So in the six months since our last blog on dissociation, we’ve learned that the standard dose of 0.5 mg/kg of ketamine is on the low end of average in effective antidepressant treatment. In our practice, a higher dose is needed in most patients before they experience deeper dissociation and remission of their hopelessness and depressive symptoms.

    We’ve also learned that by clinging to the originally tested 0.5mg/kg for the full series of six or more infusions, many patients fall short of remission. So we’ve adopted flexible dosing and adapted infusions to the individual.

    Wife helps her husband find out that dissociation quality determines remission power.

    Because remember, as we keep saying, in a private real-world practice (as opposed to a research laboratory) our goal is to help each patient achieve remission from their symptoms. That means we remain open-minded to those things that may help our patients reach their goals.

    We do what it takes.

    And we’ve just submitted a paper for peer review describing this.

    How Does Dose, Rate, and Duration of the Infusion Affect Remission?

    So with that in mind, we seek to administer the ketamine infusions with remission as the target goal, and therefore adapt dosage, rate, and duration of the infusion based on each patient’s response to this medicine in each infusion.

    Remember… 15 years ago, remission from treatment resistant disorders was pretty much unheard of. We’re exploring this frontier to find the best results for each patient.

    This is the most personalized form of medical treatment available, and it’s vital for taking a long term illness from debilitation to remission.

    So let’s go a little deeper.

    What is dissociation and what isn’t..?  Does it matter what happens in a patient’s brain during the infusion, as long as ketamine is infused into his or her body?  Isn’t this medicine delivered through the IV based on the person’s weight, like most medicines?

    These are great questions, so let’s take them one by one. The answer to the last question is NO.

    Apparently, according to some studies between 2015 and 2018, the dissociative experience is explicitly connected to reduction in depressive symptoms. Which means dissociation helps you get well.
    Dissociation determines remission quality and endurance.

    So it turns out that just infusing the body with ketamine isn’t enough. Something more is needed. Intense dissociation gives your brain what it needs to reboot… and feel joy.

    In addition, that dissociative experience is not triggered by ketamine delivered in a standard dose based on body weight. It varies between individuals and needs to be titrated according to that individual’s response.

    We see this first hand, every day. We know it.

    Now, as far as dissociation, it’s the sense of being detached from yourself, or your body. We’re not talking about a disorder here, but rather a sense, or feeling, that occurs during the ketamine infusion.

    Dissociation may includes feelings of waves splashing around you.

    You may experience a lovely floaty dreamy feeling, one where it’s like you’re daydreaming and relaxed. You may feel as if waves are splashing around you, but more in a metaphorical sense. But at the same time, you’re aware you’re sitting peacefully relaxed in a chair or recliner, but you’re not focusing on that. If someone speaks to you, you can easily respond. You’re aware of yourself, but not focused on yourself.

    This isn’t dissociation, though it may be leading to it.

    So What IS Dissociation?

    Dissociation may be hard to describe but you’ll know it when you experience it. For lack of a better term, it’s a feeling of being separate from your body or yourself while still feeling relaxed. It may seem as though you’ve left your body and are floating above it, or in another place. It’s not an unpleasant or frightening feeling, but rather a relaxed sense of freedom… and it’s often accompanied by billowing relief.

    In other cases, it may be a deep dive into your “inner workings,” your outlook and motives, your biases and self-imposed limitations… all in a flexible atmosphere where you can change the attitudes you want to change.

    In still others, it may be more spiritual in nature, a transformative, almost metaphysical experience, focused on your spiritual self.

    Remember, this is your brain. And your experience during dissociation will be uniquely yours.

    No matter what the format of your dissociation, the importance of this is that it’s a direct sign that ketamine is at work in that moment repairing the signaling structures in your brain and all the damage that stress and depression have done. It doesn’t all happen at once, but the process does start right then.

    For this reason, when you feel that “floating above your body” feeling or however it happens with you, we know it’s important that what you’re experiencing is sustained awhile.

    This crucial time sees the repair work initiated and carried out and you may begin to feel a bit better within the hour. You may even find that you feel better and better through the next day and the day after that.

    When your brain is functioning at full capacity, all the neurons are happily buzzing along carrying billions of signals all around your brain as you think about things, feel emotions, make decisions, sort through offenses, and figure out solutions.

    Each neuron brandishes branches of buds that burst into connections with other neurons forming a dense and complex network.

    You think the internet is complex? Ha! It’s a child’s toy compared to this. Every thought you form requires signals dashing around your brain pulling memory and feelings from the hippocampus and amygdala, managing impulses in the prefrontal cortex, and around and around it goes until your thought is formed.

    And the beauty of it is that it can do that at the speed of light, while you memorize volumes of scientific theory, write a speech for a women’s conference, and compose music for your recital.

    But when trauma or overwhelming stressors shove you into depression,  those signaling pathways slow down, break apart, and thin out. Then, you find yourself left with something about as sophisticated as a string suspended between two tin cans. Remember those “telephones” when you were a child? Primitive. Impaired. Ineffective.

    (You can hear some buzzing when someone talks to you but it’s hard to make sense of it. You can say something simple and try to make it heard by your friend in the tree house, but it won’t likely be the Gettysburg address.)

    Your energy to try drains away. Your ability to think complex thoughts seems to all but disappear. The ability to perform becomes so “last year.”
    Dissociation during ketamine infusions may cause strange visual images, like this melting building.

    You need a way to overcome this, but all the things they tell you to do just don’t help much at all.

    It all seems futile, and you’re too weighed down to even try much anymore.

    And then you hear about ketamine treatment and you go for your first infusion… (as in…how soon can you see me??)

    What Happens During Your Ketamine Treatment

    There is something significant that happened when Chris moved past the relaxed floaty feeling and advanced to “another room then another place…” and “let his mind float, and fly, and feel freedom.”  That sensation is the outward signal that ketamine is repairing and restoring. 

    It triggers massive production of turbo-boosted brain-derived-neurotrophic-factor (BDNF) which causes the synapses to explode into branching and proliferating connections that spread across the brain in a sort of fast motion animation.

    It happens at high speed and results in these sensations and impressions like floating then flying and swirling around.

    Dissociation quality determines remission durability. And you want your remission to last and to be resilient, right? So be sure your doctor helps you experience intense and extended dissociation.

    It seems possible – even likely – that some of those who are receiving the flat dosage of 0.5mg/kg without titration aren’t achieving sustained remission… Could it be this is why some of those are needing to return for maintenance doses every month or two?

    We have studies that show that dosing below 0.5mg/kg doesn’t work well to decrease depression symptoms. And it might be that this dose decreases depression symptoms, but is not enough to bring on actual remission.

    Is there a magic dose that always results in remission for everyone? Unfortunately, no …(wouldn’t that make things simpler?)

    Is it possible that by titrating the dose, raising it a bit higher — according to a patient’s response — it could help a patient achieve remission? Well, it’s safe to say his or her chances are much better. What do you think? I’d love to read your comments!

    With the new esketamine intranasal spray approved by the FDA, and with ketamine treatment becoming increasingly effective as we learn what it’s teaching us, hope is growing. People are getting well.

    Dissociation quality detemines remission strength, like tulips rising to the sun.

    We’re learning. All of us are learning together. The field of ketamine for psychiatric disorders didn’t come with a manual, but we’re reading, and comparing notes, exchanging experiences, and watching our patients respond. And the more we learn, the more people get well.

    Options are improving.

    Watch for word from your own insurance company in coming months about their stance with esketamine. We expect to see more and more insurers get on board with esketamine intranasal spray.

    But if you want treatment now, and you seriously seek remission, call us. And let’s work together to help you experience full and deep dissociation to the end that you may achieve remission. So you can build your life and your relationships. And work toward your dreams.

    To the joy of life as your best self,

    Lori Calabrese, MD offers innovative psychiatric treatment like IV Ketamine
    Lori Calabrese, M.D.
  • Ketamine KRIYA Conference 2018

    Ketamine KRIYA Conference 2018

    KRIYA!!

    Ketamine KRIYA Conference 2018-Dawn of a new field.

    The most phenomenal ketamine conference to date!  

    Last weekend I attended and presented at the ketamine KRIYA Conference 2018 in San Francisco. This conference emerged as the most dynamic gathering of front-line ketamine practitioners I’ve ever experienced.

    And what an event!

    The ketamine KRIYA Conference 2018 was extraordinarily different than any other research or clinical conference I’ve attended. It’s clear that the realm of ketamine treatment for psychiatric disorders is growing wider and deeper. 

    There was a true spirit of inquiry, extraordinarily open collaboration, and presentations of risks, failures, and triumphs. Sheer transparency. Openly exposed vulnerabilities. A clear admission of the limitations of what we know. The latest information about clinical uses of ketamine in psychiatry. 

    The insider news.

    What happened when Raquel put all of it — and all of us — together?

    Palpable energy instantly exploded!

    During the presentations — which were riveting. As we met for coffee. Chatted on the beautiful conference grounds, sprawled out over the steps, snugged down into comfy couches, talked over creative and inventive lunches, inhaled coffee (for some of us, all throughout the day!) — there was the sense that we needed to learn from each other as fast as we could. So … we shared Ubers and Lyfts and dinner tabs. 

    We came from all over the country … and from as far away as Russia.

    We’re serious about this.

    And what a weekend! We learned so much from each speaker and each other. We talked about our data, our practices, our experiences, what we’ve learned. What we still don’t know.

    Ketamine KRIYA Conference 2018 helped this man reach light in his life.

    Soooo many different backgrounds, so many different approaches providing patient care, so much desire to reduce suffering in our patients.

    Founded by Raquel Bennett, Ph.D., KRIYA is the Ketamine Research Institute and it is devoted to understanding the use of therapeutic ketamine in psychiatry and psychotherapy.

    I must give a shout out to Raquel Bennett.

    In such a few short years, she single-handedly founded, organized and grew KRIYA, an organization devoted to helping people heal and live fuller lives through safe, legal, and effective ketamine treatment. She is originator of the first international ketamine conference — KRIYA’s first conference, in 2015 — on the therapeutic use of ketamine.

    Raquel has earned our respect, appreciation, and applause for the enormously hard work of bringing together experts who work with therapeutic ketamine in very different ways, using different routes, for different therapeutic purposes, in all aspects of psychiatry and psychotherapy, as well as in chronic pain and hospice.

    Ketamine is a visionary medicine.

    But Raquel Bennett, Ph.D, is a visionary.  

    Fantastic speakers, wonderful food, and gorgeous (read: non-hotel) settings gave all of us opportunities to pick the brain of someone nearby. We shared, we ate, we discussed, we listened. And at the end, we kept talking until they put away the chairs, and turned out the lights … until we each left for the airport. And then checked in and kept going.

    Meet me in Terminal 2. I’m at Starbucks. Find us in the International Terminal.  We’re sitting in the food court.

    Until one by one, each had to break away to catch a plane.

     … You haven’t seen anything til you’ve seen the excitement that comes from connection.

    Many thanks to Raquel and her incredibly talented, organized and generous team for making this all possible.

    Ketamine KRIYA Conference Founder Raquel Bennett.
    Raquel Bennet, Psy.D.

    Though our backgrounds are different, and our methods varied, it was clear that we share the same passion: to help reduce suffering from psychiatric symptoms and physical pain.

    Next, let me say, I can’t possibly share it all with you here — there were 30 different speakers over 2 days, fascinating and varied discussion panels, and a lively sharing of experiences and ideas that kept us on our toes till the wee hours.

    This conference was thrilling.

    Thrilling.

    I attended KRIYA last year.  But there has been so much growth, so much more research, so many new frontiers since then … that this gathering really can’t compare.

    These 30 speakers ran the full gamut of experience with using therapeutic ketamine in psychiatry — different practice settings, different studies, varied doses, varied routes of administration, varied preparation. Varied goals.

    This was no room for small or closed minds.

    We ALL learned and grew during those two days.

    Raquel Bennett opened to set the stage for this smorgasbord of ideas. 

    She said, “We are witnessing the birth of a new field.”  She spoke about how ketamine was developed for anesthesiology and has served that field well. But the therapeutic use of ketamine has birthed a new field of ketamine in psychiatry.

    Ketamine KRIYA Conference 2018 demonstrates the difference between anesthetic ketamine and psychiatric ketamine.

    And she emphasized that the two are as different as apples and toast.

    One way they’re different is in the goals of treatment. For anesthesiologists, ketamine has been used for managing consciousness or sedation and addressing physical pain. In psychiatry, the goal of treatment is all about treating psychiatric symptoms and managing psychiatric distress.

    The second difference is in training and areas of expertise, diagnostic skills, and managing emergencies, and she described the differences between anesthesiologists and psychiatrists. Anesthesiologists are best at managing surgical emergencies, interventional pain procedures and life support.  But psychiatrists are experts in diagnosing psychiatric conditions and managing psychiatrist emergencies.

    The third difference is in the type of patient who presents for treatment.   In psychiatry, our patients need a lot of contact, a high degree of emotional safety, and a great deal of emotional support and reassurance. Things we’re deeply attuned to by our psychiatric training.

    She also talked about the differences in routes of administration as well as the dose used  for each type of patient to reach the individual goals of sedation vs. relief of psychiatric symptoms.

    Add to that the amount of preparation required in each field. An anesthesiologist can walk into the surgical area, say hello to his patient, and tell him to count backwards from 12. 

    However, psychiatrists and psychologists offering ketamine treatment invest in substantial and detailed preparation of the patient before beginning ketamine treatment — to prepare for the treatment itself, the treatment experience, and how to metabolize or make sense of the treatment experience. 

    And the preparation involves not only  a thorough history of symptoms, treatment course, previous medication and treatment failures, but also a thorough developmental and social history. 

    Our education and training centers on entering into an ongoing therapeutic relationship with our patients and the critical understanding and provision of a safe, therapeutic frame to do the deep work we do.

    These two fields are two different animals. 

    Dr. Bennet encouraged everyone to learn from everyone else, in effect, to “cross pollinate” these fields and help each other to improve in clinical practice.

    Then she described the use of ketamine in psychotherapy as a “lubricant” for psychotherapeutic work. 

    Several of the speakers described this method in their practices.  This is called ketamine-assisted psychotherapy, or ketamine-facilitated psychotherapy.

    Ketamine KRIYA Conference 2018 demonstrated what ketamine treatment can do.

    And she went a step further, to describe the use of therapeutic ketamine in psychotherapy as a tool for deep spiritual exploration. This is where the goal of treatment is not symptom relief per se, but personal growth, self-knowledge, or transcendent exploration.

    All in all, she encouraged matching the treatment to the individual patient, recognizing our responsibility to learn more about varied strategies and to share our findings within our field.

    Speakers were diverse and fascinating. If you’ve been keeping up with progress in the field of psychiatric ketamine treatment, some of these names are sure to jump out at you:

    Will Van Derveer, M.D., Wesley Rylan, M.D., Scott Shannon, M.D., Michael Stanger, M.D., Jeffrey Becker, M.D., Jason Wallach, Ph.D., Dan Engle, M.D., Lori Calabrese, M.D., John Krystal, M.D., Phil Wolfson, M.D., Jeff Guss, M.D., Elias Dakwar, M.D., George Greer, M.D., Evgeny Krupitsky, M.D., Patrick Sullivan, D.O., and Jennifer Winegarden, D.O.

    And we had some lively and fascinating panelists, including Gary Bravo, M.D., Alison McInnes, M.D., Steven Levine, M.D., Steve Best, M.D., Veronica Gold, M.F.T., Greg Wells, Ph.D., Bob Grant, M.D., Genesee Herzberg, Psy.D., Jessica Katzman, Psy.D., Jennifer Dore, M.D., Julie Megler, P.N.P., Steven Levine, M.D., Steve Best, M.D.,  Sandhya Prashad, M.D., Steve Mandel, M.D., and me.

    Oh yes, I mentioned I also presented my own data, and am excited to tell you more about that…

    But… that will have to wait for another day … Without question, our fledgling new psychiatric field has turned a corner.

    Ketamine KRIYA Conference 2018. 

    We’ll never forget this one. We can only hope they keep getting better…if that’s possible.

    As exciting as this wealth of information may be, if you’re suffering from depression, bipolar depression, PTSD, OCD, social anxiety, substance use disorders…and even suicidal thinking, don’t wait. Call us

    Thankfully, if your symptoms are mild, there are a host of antidepressants and other medicines and treatments that can hopefully help you.

    Ketamine is at its best for those who are severely suffering. 

    Ketamine KRIYA Conference 2018 educated psychiatrists to help this woman get better.

    If you’re deeply affected by severe symptoms of depression and anxiety, we can help.  Call and arrange an appointment.

    Ketamine isn’t for everyone. Of course not. It doesn’t help everyone. But even among those who aren’t helped initially… sometimes there are those who get a delayed response and in a few months reach remission quite by surprise. 

    And even though we can’t promise everyone they’ll reach remission, the truth is that a very large percentage do.

    As we’ve said before, ketamine is the most rapid and effective treatment for depression that we’ve seen in our lifetime … and really … ever.

    We’re constantly learning ways to help more people benefit and get better. And chances are…you’ll experience the most remarkable transformation you could have imagined.

    Our Results

    At Innovative Psychiatry, we see people with these symptoms and disorders get better every week with ketamine treatment. Our results are extraordinary, and our remission rate is very high. Call for an appointment and let’s talk.

    Ketamine works in some different areas of the brain in different ways than traditional medicines you might have tried that didn’t work for you. Your life really can improve dramatically.

    Find out what this remarkable treatment can do for you.

    Ketamine KRIYA Conference 2018
  • So You Want to Buy Esketamine Nasal Spray… Really??

    So You Want to Buy Esketamine Nasal Spray… Really??

    Is It the Hype…?  Or Is There Something about Esketamine You Really Want…?

    Ok,  you’ve been wishing for a remedy for your distress with this mood disorder.  I get it. Something that will do more than take the edge off, but instead will really help you feel good again. You’ve heard about ketamine treatment, but having to go to an office and undergo IVs 6 times sounds just a bit daunting..? Then you heard about esketamine nasal spray, and that it’s close to receiving FDA approval. And it’s a nasal spray! How easy is that??

    What’s more, you’ve looked on the internet and its cost will probably be a great deal less than a series of IV ketamine infusions in a doctor’s office because you should be able to administer it yourself..? What a perfect alternative! …or is it?

    So your excitement is building that hope is around the corner…within a few short months…or maybe even weeks…?

    But wait…

    Take a breath…ok?  Of course, it’s possiblebut…

    Just a couple weeks ago, Janssen (a company under Johnson & Johnson’s umbrella) announced that things haven’t been going all that well with their testing. 

    Well, they didn’t exactly say it like that.

    You know that it takes a ginormous amount of testing to get FDA approval on a drug. And all that testing costs lots of money.

    When a pharma company pours years of resources into R&D (research and development), they hope the compound they’ve made will do what it’s designed to do, what it’s supposed to do. But they’re taking the risk it may not.

    And they have lots of investors to please.

    It’s a bit early to make judgments about esketamine nasal spray. Janssen has had some good trial results, but some weren’t that convincing at all.

    Back in May, they made an announcement that even though they’d had both promising and disappointing results with esketamine nasal spray, they weren’t discouraged about its potential. They were determined to continue the trials.

    Esketamine doesn't help social anxiety for this mean but ketamine can make him well.

    Of course, investors want to see a return on their investment. Insignificant or conflicting results won’t butter their bread, if you know what I mean. 

    Then, after announcing September 4, 2018, that they were applying for a New Drug Application (NDA) for esketamine, a few weeks later they announced that esketamine failed yet another study in their Phase III trials.

    They said esketamine nasal spray had failed to meet its primary end point in this study…to lower the depression scale for these subjects significantly from the level they were at the beginning by 4 weeks after the esketamine doses began.

    Frustrating for Janssen.

    So much money, so much work, in laboratories across the globe.

    So, let’s take a closer look at Janssen’s quest for FDA approval of esketamine.

    It’s easy to understand that even as they made the announcement that esketamine had failed this study, they continued to point out all the tests it has passed. Reminding investors that a disappointment is no reason to throw the baby out with the bath water. (At least, they hope that won’t happen.)

    When they filed the NDA on September 4, it was based on 5 Phase III studies of esketamine in treating people with treatment-resistant depression: 3 short term studies, one “withdrawal maintenance of effect” study, and one long-term study.

    The long term study was aimed at establishing the safety of esketamine use up to 52 weeks, and it found that esketamine is generally well tolerated. Not that surprising, since ketamine is well-tolerated in controlled, small doses.

    HUGE Disappointment for Janssen

    But this most recent study, where results were announced September 21, 2018, showed esketamine nasal spray failed to meet a primary end point. It did not have a statistically significant positive effect in reducing depression symptoms in the subjects. Janssen is quick to say however, that even though the response didn’t meet the goal it was intended to meet… the numbers still support the use of esketamine combined with an antidepressant.

    Esketamine failed to relieve depression in this woman, but ketamine helps her achieve remission.

    Really…?? How is that?

    You get the feeling Janssen tries to do damage control in  each of its press releases…. Pay attention to the good stuff…and minimize the bad. (There seems to be a lot of that going around.)

    Still, look at this: The trial investigated esketamine plus an antidepressant at two different doses, 84mg and 56mg. The plan was to test both doses.

    However, the larger dose didn’t shake out better than placebo! So obviously there was no point in testing the lower dose.

    What a blow for Janssen. 

    I’ve not made it a secret that I’m skeptical of esketamine nasal spray. But, I’ll concede for now that the jury is still out as psychiatrists and researchers evaluate all of the results coming in from all of the clinical trials. 

    We’ve got a medicine with IV ketamine treatment that works — and more and more basic science, translational, and clinical research supports this. But look at all the cards stacked against esketamine.

    And…if the goal is to have a nasal spray form that’s more affordable, comfortable, and accessible to more people, that’s understandable.  We get it. (Even if that nasal spray form would make it easy to hide, easy to share, and easy to abuse. Those risks are formidable risks that need to be addressed.)

    But why use just esketamine when ketamine works so well?

    You know why.

    Because of money.  Ketamine can’t be patented after 50 years of use. Esketamine can be, if they can just get it to work…even half as well.

    To take this a step further let’s look at the problem that happened in May.

    May 2018 Press Release More of the Same

    So in May, Janssen made another announcement. That it had just completed 2 studies in its Phase III trials. In one of the two studies, they announced that in a group of subjects 65 or older, esketamine nasal spray had failed to show statistically significant findings. (Yep, just like it did in this most recent study.)

    Esketamine nasal spray isn't working like ketamine would for this worried man.

    So…wait…Does that mean 2 out of 5 studies failed to show any significant advantage over a placebo…?

    Now let’s be clear.

    In all of these studies, Janssen is investigating esketamine nasal spray  in conjunction with an antidepressant in comparison to an “active” placebo compound delivered by nasal spray along with an antidepressant.

    So, even with esketamine bolstered by an antidepressant like Lexapro, Cymbalta, Zoloft, or Effexor… esketamine showed no statistically significant beneficial response in patients with treatment-resistant depression. Even at the highest dose they tested.

    Reasons Why Esketamine May Fall Far Short of IV Ketamine Treatment

    1. It’s NOT ketamine!  Esketamine is only the left-facing form of ketamine . Ketamine consists of right- and left- facing forms and esketamine is the left-facing.  So with esketamine, some of the beneficial aspects of having both available may be missing. We’d love to think esketamine is the important one, and that maybe it does all the work, right? But…maybe not. 

    2. Traditional SRIs and SNRIs have not helped a full third of people suffering psychiatric disorders…so why would adding these partially effective medications help esketamine do a better job??

    3. It’s a nasal spray, for goodness’ sake. Let’s talk about that.

    Problems with Esketamine Nasal Spray

    We’ve talked before about the differences in various routes of administration with ketamine.

    Esketamine nasal spray doesn't work as well as ketamine for this man with high anxiety.

    A huge factor is bioavailability.  You know, the amount of medicine that actually reaches your brain to treat it. Everything else is digested, or somehow altered, or bound by proteins, or otherwise eliminated by your body … which does you no good at all.

    We give ketamine by IV, so it can go straight into the blood stream and straight to your brain where it’s needed to treat the problem. Virtually 100% of the ketamine we infuse into your blood stream goes exactly where it’s needed. And because the brain’s structures and systems are so very delicate,  we want to be very precise about how much reaches it and how fast.

    With a precise infusion pump and IV access, we can control those factors exactly. There are no obstacles that prevent ketamine from reaching the systems in the brain in the amount we want, at the rate we want. And we can slow it, and we can stop it at any time.

    But what is it about a nasal spray?

    In the case of a nasal spray, there are all sorts of variables.

    It has to be absorbed through mucous membranes to find its way into your bloodstream. 

    So picture this: 

    • It has to emit a spray that’s a perfectly suspended and evenly concentrated mist to saturate your mucous membranes—that are hopefully healthy enough and not bogged down by inflammation from allergies or a cold to absorb it properly.  (It wouldn’t be a good thing if some days you can’t absorb your medication because you’ve got a cold.)
    • When you spray it into your nostril, it has to be aimed just right…high enough that it won’t drip right back out your nose and straight enough that it will be absorbed before it runs down the back of your throat and into your stomach to be digested — where it’s bioavailability will drop even further.
    • It has to be sprayed so carefully that none is wasted in the air and gently enough that it isn’t sneezed right back out.

    Then add to all this, that once sprayed, there are only a few seconds for absorption to bring change to the critical and delicate brain systems…the ones vital to you getting better. 

    With IV ketamine, there are at least 40 minutes that ketamine is being continuously infused into the blood stream reaching the brain at a precise dose and rate.  40 minutes vs. a few seconds!

    Esketamine nasal spray has been in the news all this year…and last year too.

    Anytime Janssen has an announcement to make about esketamine we want to hear it.

    Even if it’s disappointing. Not meeting a primary endpoint on its large major Phase III trial for approval?  HUGELY disappointing. Shocking, really.

    Esketamine nasal spray didn't help her, but with ketamine treatment she's in full remission.

    So, while we wait, we’re so thankful we do have ketamine treatment. It doesn’t work perfectly and it doesn’t work for everyone. But when it does, it can save lives by stopping suicidal thinking in 4 hours or less. It can bring relief and remission to those who suffer the most with severe depression, bipolar disorder, social anxiety, PTSD, OCD, substance abuse disorders… It works fast.

    And extremely well, better than anything we’ve ever seen.

    At Innovative Psychiatry we see so many patients who get better every day.  Not just 50% better, but completely better. We see them achieve remission, and they go on to enjoy life as the best they’ve ever been.

    They’re creative again, motivated, full of initiative …and hope. With lives that have meaning. And they’re glad to be alive.

    So if you’ve invested your hope in esketamine nasal spray, don’t let disappointing news stories push you to give up.  

    There’s still all kinds of hope available that we’ve never had before. It just isn’t in esketamine nasal spray.

    At least not yet.

    But ketamine is still going full steam ahead helping many patients who thought they were treatment-resistant turn around… heal… and be restored.

    To enjoy their lives fully.

    If you suffer from treatment-resistant depression, and the problems that often go along with it, call us.

    We’re all about helping you reconnect with the best you you can be.

    Lori Calabrese, MD offers innovative psychiatric treatment like IV Ketamine

    To the restoring of your best self,

    Lori Calabrese, M.D.

  • ASKP Meeting Notes:  The 2018 Inaugural Conference of the American Society of Ketamine Physicians

    ASKP Meeting Notes: The 2018 Inaugural Conference of the American Society of Ketamine Physicians

    New Advances in Ketamine Treatment

    2018 has been a good year. A very good year.

    In this fall season of harvest and bounty which surrounds us outdoors, we find ourselves as ketamine physicians with wonderful gifts to work with:  in our world of neuroscience and psychiatry, the soil is rich, the seeds have been planted, and hard work has been done – sometimes for years! – by experts who have paved the way, and brilliant emerging experts whose work and insights inspire us all.

    I’m talking about the 2018 ASKP Meeting in Austin, TX.

    Ya shoulda been there

    It was the Inaugural Meeting of the American Society of Ketamine Physicians – hence, ASKP – and it was a conference that fueled excitement, embraced inquiry, acknowledged the need for temperance … and left all of us thirsting for more opportunities to work, study, collaborate, and publish.

    I want to tell you about the meeting.

    Especially if you or someone in your life suffers from a mood disorder. If you’ve been struggling for a terribly long time. If you’ve begun to think of yourself with symptoms that have become “treatment-resistant.”  Sound familiar? Then dial in to learn about IV ketamine treatment advances.

    What you learn may help you think outside the box you’ve found yourself in.

    Hard Pruning Can Leave You Unable to Recover

    Ketamine treatment advances help more people escape depression.

    As you know, it’s terrible to struggle to live your life when your confidence, your hope, your ability to think and perform, are all dulled, impaired…broken down.

    Major depression, panic disorder, social anxiety, PTSD, OCD, bipolar disorder, addiction … the list goes on …  all of these can make it nearly impossible to reach the goals you may have for your life.

    You’ve probably seen your doctor and tried some different medicines, but if you’re not feeling better, you may be part of the large group of depressed or anxious people for whom conventional medications don’t work.

    If you’ve heard of ketamine, you may know that it’s showing great promise for helping a majority of people who weren’t helped by antidepressants.

    But, you may not have been able to find someone who administers ketamine treatment properly. Because until recently doctors have just been on their own offering ketamine the best way they know how.

    Sometimes their methods don’t work very well.

    So physicians who provide ketamine treatment are beginning to organize into groups to exchange their ideas, experiences, and discoveries, in hopes of solidifying some of the true “best practices” that provide the best outcomes for their patients.

    An important organization that’s doing this is the American Society of Ketamine Physicians, or ASKP — and we just held our Inaugural Conference September 20-22, in Austin, TX.

    Let me start by saying how grateful I am for the many opportunities to meet with other medical pioneers who are committed — like we are — to helping people who suffer with treatment resistant psychiatric disorders.

    Ketamine treatment advances lead to more remissions.

    Conferences are a festival for the mind.  Ideas spark, slides fly by, data positively crackles in the air — and so does good humor, agreeableness, collaboration, and humility.  We are humbled by the pain our patients experience, and inspired by our colleagues to learn more, think critically, design carefully, proceed with integrity.

    We are privileged to have ketamine in our toolbox and to be able to offer ketamine treatment to patients whose suffering has become unbearable.

    ASKP is helping us do just that. 

    IV Ketamine Treatment Advances: Leaders

    We were treated to a lineup of seminal leaders in the field. Steve Mandel, M.D., the President of ASKP and Ketamine Clinics of Los Angeles, James Murrough, M.D., of Mount Sinai and Sam Wilkinson, M.D., of Yale, Steve Levine, M.D., of Actify Neurotherapies, Carl Bonnett, M.D., of Klarisana in San Antonio who has been working with veterans for years treating depression, PTSD and pain; Rupert McShane, M.D., whom I met at KRIYA and Oxford, Raquel Bennett, Ph.D., the founder of KRIYA Institute and the KRIYA Conference, and Jason Wallach, Ph.D, of University of the Sciences, a brilliant synthetic chemist and expert on the pharmacology of ketamine and related novel NMDAR antagonists. 

    Dr. Mandel’s opening address caught everyone’s attention when he opened with statistics about suicide. He reported that 44,000 people die by suicide each year, and 25 times that number attempt to end their lives. There are more suicides among physicians than any other profession.

    Ketamine treatment advances can transform depression to joy.

    He stressed that there are so many people who need this medicine and not nearly enough doctors providing it — if for no other need than to help prevent suicide. But of course, we shouldn’t stop there.

    He also pointed out that in his practice, he’s seeing more and more patients who have a delayed response, just as we see at Innovative Psychiatry.

    Because of this, it’s so important that if you don’t feel better after your series of infusions, that you must not give up. You may be a late responder and we’re learning more about this all the time.

    Extensive Research That Began During Residency

    James Murrough, M.D., Ph.D., was next and he talked through the history of ketamine’s research for treating psychiatric disorders. He spoke of Carlos Zarate’s work in 2010 which was the first study in patients with treatment-resistant bipolar disorder.

    He got involved in ketamine research as a resident  in a study of 47 patients led by Sanjay Mathew, MD who, with Zarate, co-authored the book Ketamine for Treatment-Resistant Depression. It was a difficult study, and ketamine treatment was surrounded by skepticism at the time. (For some people, it still is.) But it was the largest number of patients studied clinically at that point.

    Dr. Murrough did a beautiful, comprehensive review of the clinical literature on ketamine’s effectiveness. He and his team published a study in 2015 that demonstrated that ketamine’s effect is rapid and robust.

    Then, studies accumulated that showed ketamine’s effect lasts longer when given in a series. (Which is why we give a series of 6 – 9 at Innovative Psychiatry.)

    Groundbreaking studies…over and over and over. 

    Steven Levine, M.D., talked about what he’s learned through 30,000 ketamine infusions with 3000 patients over the past several years.

    And he made the point that stress itself is a risk factor for relapse.

    Raquel Bennett, Ph.D.

    I don’t have room here to tell you enough about every presentation, but really quickly I want to tell you about Raquel Bennett’s presentation. 

    Raquel Bennett, Ph.D., spoke about the varied ways ketamine is used in psychotherapy and the importance of selecting patients appropriately for each type of treatment.  

    She also chaired a panel discussion with Eli Kolp, M.D., Robert Grant, M.D., and Jeff Becker, M.D., about their varied therapeutic approaches and their work with ketamine in psychotherapy.

    Sandhya Prashad, M.D., spoke about the hallucinogenic potential of ketamine. While many physicians have been reluctant to delve into this aspect of ketamine, the dissociative symptoms patient experience are key to their improvement.

    This wonderful gathering included research scientists, clinical researchers, full-practice physicians, and psychologists who explained their own discoveries for us to assimilate.

    So many luminaries, so little time…

    Rupert McShane, M.D.

    Sam Wilkinson, M.D., explained the challenges of research and reviewed key studies. Rupert McShane, M.D, presented data on oral ketamine and abuse concerns. I first met Rupert at the KRIYA conference and he encouraged me to attend the Oxford International Conference on Ketamine for Psychiatric Disorders 2018 conference last March. He chaired the Oxford event, which was spectacular. He’s been generous with his mentorship in so many ways. Such a lovely man.

    Rachel Dalthorpe, M.D., talked about hormonal factors in ketamine infusion treatment. She referred specifically to premenopausal women and proposed an ideal time during the menstrual cycle for scheduling follow up infusions. Such valuable information.

    I was delighted to see so many of the luminaries there who have previously spoken at Kriya… like Jason Wallach, Jeff Becker, and Steve Levine … and from the Oxford Conference like Rupert McShane and Jenny Southgate … Such friends … and such a hall of fame!

    Benjamin Keizer, Ph.D., talked about pain and the impact it has on the brain. Jennifer Southgate, Ph.D., spoke about her work with urothelium and bladder inflammation, and how ketamine can affect the bladder. 

    Ronald Hertz, M.D., explained his important work on the use of ketamine for treating severe and chronic pain…and CRPS. Randall Malchow, M.D., talked about his own studies treating pain. Jason Wallach, Ph.D., spoke on the pharmacodynamics of ketamine, expounding on the history of derivatives of PCP. He also discussed the difference between r-ketamine and s-ketamine. He is brilliant, engaging and makes chemistry fascinating.

    Ketamine Advocacy Network Helps Physicians and Patients Alike

    Finally, Dennis Hartman, who founded the Ketamine Advocacy Network, spoke about the extreme importance of patient advocacy. I was delighted to meet Kim Juroviesky. Kim hosts a Facebook group for ketamine patients, which is growing fast and helping so many.

    Ketamine treatment advances help you perform in your job.

    The entire two days was chock-full of data, expert opinions and suggestions regarding clinical use of ketamine.

    What an inauguration! Ketamine treatment is growing rapidly in use and in its positive effects. The more we can learn, the better able we are to effectively treat more patients with bright outcomes.

    IV ketamine treatment advances help you transform.

    At Innovative Psychiatry, we administer ketamine and other treatments for treatment-resistant mood disorders. And we align our methods with best practices to help you achieve the most favorable outcome.

    If you suffer from severe depression, social anxiety, bipolar disorder, PTSD, OCD, substance abuse disorder, and suicidal thinking, please call us.

    And know that you don’t have to suffer with your symptoms. Let us help you find the life you want to live, and discover the best you, you can be.

    Lori Calabrese, MD offers innovative psychiatric treatment like IV KetamineTo the reinvigorating of your best self,

    [line][line]

  • Why Ketamine Over Esketamine? It Works and It’s Available NOW

    Why Ketamine Over Esketamine? It Works and It’s Available NOW

    Why ketamine over esketamine? Because it's twice as effective.Treatment for Psychiatric Mood Disorders Has Been Quietly Waiting To Do Its Magic for 50 Years

    He was 48, in the midst of a booming career, and like some others who demonstrate that special kind of genius, he had periods when depression came over him unexpectedly…and made it extremely difficult to function.

    Because of his star-level performance most of the time, his boss gave him some room during these times to find “whatever he needed to find” to get back on his feet. It was humiliating…and he felt powerless to change it. He wished he could disappear into a hole and never come out.

    After a lifetime of trying to physically and mentally brute his way through the days, training himself to function anyway no matter what…using muscle memory...he was growing weary of the battle.

    Prolonged Years Fighting a Mood Disorder – Demoralizing

    These long bouts made him feel foolish and stupid…like he couldn’t find two thoughts to rub together, and anyone who knew him could certainly see the pain and vulnerability in his face.

    His productivity and accomplishments tanked during these times, and co-Why ketamine over esketamine? Because it's twice as effective.workers made insensitive and cruel remarks.

    “They’re jealous, honey,” his wife tried to soothe him. “Because they can’t keep up with you most of the time. You’ll be yourself again…just hang on.”

    Finally, in desperation, he decided to pick up the card his sister had given him six months ago for a psychiatrist she really liked, and make a call. He didn’t know what he’d say…but at least he was calling.

    …You Have to Take the First Step

    Mary answered the phone. She had a soft voice, and she didn’t sound rushed. And at the end of her greeting, she asked him, “How may I help you?” It blew his mind. He didn’t know.

    So he hesitated. He hadn’t called a doctor’s office in years.

    “Uh. I’m wondering if I could have an appointment. I’m in bad shape. A couple times a year I get like this. Depressed, I think, but it makes me feel dumb, and weak. 

    “May I ask your name?”

    “James.”

    “Thank you, James. I think you’d really give yourself a chance to feel better if you met with the doctor as soon as possible. She has a number of advanced forms of treatment for depression that might make a real difference for you.”

    “Well, I ran out of hope a long time ago.”

    “Not today you didn’t–you called!”

    When James arrived at the office, it was his Hail Mary last ditch effort. He sat Why Ketamine Over Esketamine? It works and it's available now.down in the waiting room and spotted beautiful binders with The Ketamine Library on the front.

    They were filled with articles and studies about ketamine treatment. It seemed the more he browsed, the more the articles answered any question he could think of…Something new for depression. hmmm.  As he began to read the articles, he was astonished at the reports people gave and how much better they felt…

    The articles also referred to esketamine, something about mirror images … and said it wasn’t yet available. He wondered why it was advertised when it wasn’t yet available. And he wondered how the two were related… so he kept reading…until his name was called. He stood up and walked into the office, hoping beyond hope that this time would be different

    Why Ketamine Over Esketamine  (Still Testing for FDA Approval)

    As esketamine nears completion of its FDA trials, and crawls closer to the Why ketamine over esketamine? Because it's twice as effective.coveted approval status, people all over the US who suffer from mood disorders are clamoring for more information.

    Why Ketamine Over Esketamine?

    The answer is rather logical.

    Recently, I was asked some questions about the behavior of s-ketamine and r-ketamine, the two enantiomer Siamese twins that you get when you divide the ketamine molecule. S- stands for left, and it’s the left half of the ketamine molecule that has been named esketamine.

    Someone said he had been excited about esketamine, but as he understands more about it, his enthusiasm is waning. So he asked:

      • What is an AMPA receptor?
      • Is it a part of the NMDA receptor, or a separate thing itself?
    • And is it possible that there could be a synergistic effect of ketamine (Dextro + Levo) combined — meaning is it necessary to have both halves of the ketamine molecule to get the full benefits when ketamine is used for depression and other psychiatric disorders?

    Why Ketamine Over Esketamine? Because It Works…and It’s Available NOW

    This was my response:

    “Thanks! Wow–these are great questions!

    “There are 3 kinds of glutamate receptors: NMDA receptors, Why ketamine over esketamine? Maybe because it's twice as effective.AMPA receptors, and kainate receptors. (Each kind has variants.) So AMPA receptors are just one of the 3 kinds of glutamate receptor and they’re different from NMDA receptors. They exist independently of NMDA receptors but they can be on the same cells next to NMDA receptors–and they often are.

    Even though there is so much interest in glutamate receptors, it’s the AMPA receptors that are really responsible for the majority of FAST excitatory transmission in the brain.

    “And it’s the changes in AMPA receptors that are really at the core of synaptic plasticity.

    The Nitty-Gritty On NMDA vs. AMPA Receptors – Clearing the Fog

    “And long-term synaptic plasticity can last from minutes to a lifetime–a brilliant phrase that’s well known in neuroscience. Hold that thought.

    Here’s where it gets so exciting: a molecule (let’s think medicine) can bind to an NMDA receptor or to an AMPA receptor.. or to either or to both. Sometimes, a molecule can bind to an NMDA receptor and when it does, the NMDA receptor tells the neuron to make more AMPA receptors and bring them up to the surface quickly

    “Then, the numbers can increase rapidly, dramatically, and can stay high. Why ketamine over esketamine? Maybe because it's twice as effective.This helps create quick responsiveness, flexibility, growth and change….and it can be for the long-term.

    Ketamine binds to NMDA receptors. And for a long time, people thought this was why it helped with depression. But then a lot of other drugs that bind to the same place failed when tested in depression and function as antidepressants.

    “Hmmm…

    The More We Learn, The Better It Gets

    “What we now know is that ketamine directly binds to AMPA receptors and directly increases their numbers and the phosphorylation of those receptors (i.e., the activation of them) — wow! If AMPA is a major player in plasticity (and it is!) and AMPA production, activation, and movement in neuronal members increases long-term synaptic plasticity (and it does!), it may help you understand why we are all so incredibly excited about using sub-anesthetic doses of ketamine for depression: because it not only directly activates NMDA receptors (which can up the number and the location of AMPA receptors on the same cells), and because it also directly activates AMPA.

    “More action, more firing, more growth… more opportunity for flexibility of thought, more opportunity for the kinds of changes that people with depression want to see in their lives.

    “We see this every day in my office.

    “Finally, it’s possible that there is a synergistic effect when both the r- and s- forms (the dextro- and levo- forms) of the ketamine molecule are present — which is what we use in our IV ketamine infusions. I need to explore this more, and we need more research into which form of ketamine — the r-, the s- or the racemic compound — best activates AMPA.

    “Calling all neuroscientists!”

    Another Question: Why Aren’t All Doctors Seeing Equal Results?

    Truth be told, this is only a smattering of questions we’re all asking about ketamine,  about esketamine, and about what might be the best treatment for the majority of patients who suffer with symptoms of major depressive disorder, panic disorder, social anxiety, bipolar disorder, PTSD, OCD, and substance use disorder…not to mention suicidal thinking.

    Because there are a variety of ways doctors are administering ketamine, and Why ketamine over esketamine? Maybe because it's twice as effective.because research is going on in laboratories and hospitals around the world to better understand what ketamine does, how it works, and what its limitations are, there are mixed reports coming from all directions.

    Outstanding Outcomes Emerging in Private Practice

    My intent in telling you what I see is to inform you to make the best decisions for your health. And at Innovative Psychiatry, we’re seeing the majority of our patients with treatment-resistant disorders enter remission daily, weekly, and all the time in between.

    Now it’s true that there are some patients who don’t seem to be helped by ketamine, and we don’t yet know why. But. We’ve found that even some who weren’t helped initially…and went home disappointed…later responded to the treatment and entered remission within a few months. We can’t explain that….

    It does matter how this medicine is administered, and we adhere to the bestWhy ketamine over esketamine? Maybe because it's twice as effective. research, the best recommendations, and the best psychiatry we can offer — and we see outstanding… really extraordinary… results with IV ketamine treatment. We know that all doctors, and all clinics, aren’t getting the best results. But those of us who are … well, we know at least part of the reason why.

    The only thing that motivates us here at Innovative Psychiatry — and always has — is finding solutions that help our patients get better. So they can live and enjoy their lives, their work, and their families. 

    If you’ve tried at least two traditional antidepressant treatments with no relief, ketamine treatment may be the solution. It has been for over 80% of our treatment-resistant patients up till now. No other medicine for mood disorders has come close.

    If you haven’t been helped by other treatments, call us.

    This is National Suicide Prevention month, and we’re here to tell you that ketamine treatment can stop suicidal thinking in just a few hours. Often less. So that when those obsessive thoughts of death and dying stop, you can use the freedom that gives you to really dive into treatment and therapy that can help you save and rebuild your life.

    Find out how much better you can feel. 

    Lori Calabrese, MD offers innovative psychiatric treatment like IV KetamineTo the reinvigorating of your best self,

    Lori Calabrese, M.D.

error: Content is protected !!